Insider · CIK 0001984065
Pierre Gravier
Files at FLNA (CASSAVA SCIENCES INC), PTCT (PTC THERAPEUTICS, INC.). First filing Feb 21, 2025, latest Jul 17, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PTCT: PTC THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 12Weak | PTC THERAPEUTICS, INC. | $124k 2,516 shares | -3% | +48% from low-16% from high | |
| 27Weak | PTC THERAPEUTICS, INC. | $117k 2,335 shares | -3% | +56% from low-3% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 15, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -2,516 | $49.46 | $124k | 71,920 | Jul 17, 2025 |
| May 23, 2025 | FLNA CASSAVA SCIENCES INC | AGrant or award Stock Option (Right to Buy)derivative | +26,500 | $0.00 | $0 | 26,500 | May 27, 2025 |
| Feb 19, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,168 | $50.10 | $59k | 75,603 | Feb 21, 2025 |
| Feb 20, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,167 | $50.12 | $58k | 74,436 | Feb 21, 2025 |
| Jan 3, 2025 | PTCT PTC THERAPEUTICS, INC. | AGrant or award Common Stock | +22,500 | $0.00 | $0 | 76,771 | Jan 7, 2025 |
| Jan 3, 2025 | PTCT PTC THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +56,250 | $0.00 | $0 | 56,250 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.